Cargando…
Serum amyloid A and inflammation in diabetic kidney disease and podocytes
Inflammatory pathways are central mechanisms in diabetic kidney disease (DKD). Serum amyloid A (SAA) is increased by chronic inflammation, but SAA has not been previously evaluated as a potential DKD mediator. The aims of this study were to determine whether SAA is increased in human DKD and corresp...
Autores principales: | Anderberg, Robert J, Meek, Rick L, Hudkins, Kelly L, Cooney, Sheryl K, Alpers, Charles E, Leboeuf, Renee C, Tuttle, Katherine R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4346621/ https://www.ncbi.nlm.nih.gov/pubmed/25531567 http://dx.doi.org/10.1038/labinvest.2014.163 |
Ejemplares similares
-
Serum amyloid A and inflammation in diabetic kidney disease and podocytes
por: Anderberg, Robert J, et al.
Publicado: (2015) -
Serum amyloid A and Janus kinase 2 in a mouse model of diabetic kidney disease
por: Dieter, Brad P., et al.
Publicado: (2019) -
Novel Therapies for Diabetic Kidney Disease: Storied Past and Forward Paths
por: Dieter, Brad P., et al.
Publicado: (2015) -
The phenotypes of podocytes and parietal epithelial cells may overlap in diabetic nephropathy
por: Andeen, Nicole K., et al.
Publicado: (2015) -
Pathology identifies glomerular treatment targets in diabetic nephropathy
por: Alpers, Charles E., et al.
Publicado: (2018)